AbbVie Remains Confident About Rinvoq Despite Coming Safety Labeling Update

 
• By Joseph Haas
  
Business growth
AbbVie remains optimistic about Rinvoq growth despite pending FDA label revision
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business